News: ABSPIE recent initiatives

dr Leandro Pecchia has been invited as Young Scientist in the WLF 2020 Young Scientist Forum 8 - Artificial Intelligence Session I

Artificial intelligence and innovation information technologies are now ubiquitous, and they are growing in importance in almost every discipline. Young scientists from the U.S.A., Singapore, China will present applications of artificial intelligence in smart cities and new infrastructure, tailing mining industry, laboratory automation, and the social media experience. There is also discussion of robots to support commercial and emergency scenarios, as part of a smarter future.

Demographic changes push the NHS to contain costs, while keeping healthcare safe and effective. Hospitals remain a critical node of the NHS accounting for the majority of helathcare costs.

We are part of a European team that has been awarded a new Horizon 2020 project, for changing clinical and logistic procedures in hospitals using Artificial Intelligence, Internet of Things and robots.

Read more details here

Yesterday, 16th of September 2020, the President of the European Commission von der Leyen announched the "we need to strengthen our crisis preparedness and management of cross-border health threats."

She also announced a very clear plan:

As a first step, we will propose to reinforce and empowerthe European Medicines Agencyand ECDC – our centre for disease prevention and control.

As a second step, we will build a European BARDA – an agency for biomedical advanced research and development. This new agency will support our capacity and readiness to respond to cross-border threats and emergencies – whether of natural or deliberate origin. We need strategic stockpiling to address supply chain dependencies, notably for pharmaceutical products.

As a third step, it is clearer than ever that we must discuss the question of health competences. And I think this is a noble and urgent task for the Conference on the Future of Europe. And because this was a global crisis we need to learn the global lessons. This is why, along with Prime Minister Conte and the Italian G20 Presidency, I will convene a Global Health Summit next year in Italy. This will show Europeans that our Union is there to protect all."

This launch of the BARDA is a great news, which will position Europe at the first place for the biomedical engineering research and innovation.

Link

The Applied Biomedical Signal Processing Intelligent eHealth (ABSPIE) Lab has been deeply dealing with COVID-19 since the first few cases in the UK.

Led by Dr Pecchia, the ABSPIE Lab multidisciplinary Team has been involved in several activities, briefly described below, giving a significant contribution to tackle the COVID-19 pandemic.

Our lab, has been very active in responding to request of help and support for COVID-19. In particular three members of our Lab, Dr Leandro Pecchia (Reader), Dr Silvio Pagliara (PDRA) and Mr Davide Piaggio (PhD student) are proactively taking part in a volunteer-based response to the COVID19 pandemic.

As the world is plagued by the recent outbreak, the healthcare settings of all the countries (independently from the level of income and resources) are being challenged. The truth behind this haunting nightmare is the fact that no country was ever perfectly prepared to tackle such a pandemic. Already Italy, which has one of the best healthcare systems in the world , is struggling to keep up with the ever-increasing number of patients who need hospital care or intensive care. The number of available beds is plunging along with the number of healthcare personnel (who is getting infected too) and of the available personal protective equipment.

To this purpose, the effort of the healthcare staff (including retired workers and freshly graduates who made themselves available to help in this collective effort), incessantly working overtime despite the health-related risks, is assisted by clinical and biomedical engineers, who, despite having a more “hidden” role in this fight, are another vital engine of the response. Clinical and biomedical engineers, in fact, are normally in charge of verifying that all the medical devices and medical equipment are compliant with international standards. Only a strict compliance with such standards guarantees the efficiency of medical devices and the safety of their users.

On the one hand, a positive role in this critical situation is being played by international and local manufacturers (e.g., JLR, Dyson, Ferrari etc.), who are converting their usual production line in order to produce hand sanitizers, ventilators, respirators and face shields. On the other hand, a negative role is being played by all the self-proclaimed “Archimedes”, who suggest creative alternatives to tackle some of the above-mentioned problems using their social media coverage. We are not far from a MacGyver’s episode, in which the protagonist creates gadgets with whatever he has available. The innumerable solutions one can come across on the internet span from using baking paper to reproduce a face mask to 3D printing respirators using cotton filters, claiming that they are effective in filtering the virus.

Although many of these “Archimedes” may be doing this bona fide, the scientific community has to make clear the fact that the only approved solutions are the ones that have obtained a CE mark. The roads to the CE marks are different and depend on the risk-category which the device is part of. The common denominator among these different paths is that there are a series of tests that need to be performed, depending on the type of device and equipment.

The ABSPIE Lab has been dealing with international standards for a long time, as one of its research streams deals with the design of medical devices resilient to low-resource settings, one of the questions being: “to which extent can international standards be stretched and still be effective?” Strengthened by their field experiences in Africa, Leandro, Silvio and Davide are incessantly working with the International Federation of Medical and Biological Engineering (IFMBE) and the World Health Organization (WHO) in order to supply guidelines for helping who wants to help in this world crisis. The ABSPIE Lab is also backing up many university-led responses and companies who are revolutionizing their production line as a response to these urgent needs.

Beyond its support on this matter, the ABSPIE Lab has also supported a telemedicine company in adapting their platforms for COVID monitoring of patients and self-isolated citizens. This system is now serving hundreds of self-isolated patients and citizens in the Rome Region for three local National Health Service (NHS) Trusts, and discussion is going on to open the same platform to UK NHS Trusts for high-risk populations (e.g., cancer patients).

Lastly, as the scientific community has stated, SARS-CoV-2 is not a transient problem. Therefore, we will need to coexist with this virus forever, hoping that new cost-effective vaccines and therapies will come and will mitigate the risks. While vaccines and therapies are under development, we also need to be ready to early detect COVID19 from symptoms. This is actually the challenge for next winter. In response to this need, the ABSPIE Lab is trying to develop an AI system to detect pneumonia from symptoms (e.g., coughing, pain…) based on non-COVID specific data collected in Bosnia-Herzegovina.

Overall, there are many non-trivial challenges related to this pandemic, which should be left to people who have the right competences. The way forward in this collective response needs to be led by responsible thinking, responsible action and also responsible silence, when we do not have specific competences.